aaa agent insurance

Cook Medical News
Cook Medical News Releases

• Cook Incorporated, A Division of Cook Medical, Names Aimee Hawkins-Mungle Vice President of Administrative Services and Payroll
  Bloomington, IN, December 16, 2008 – Aimee Hawkins-Mungle, a 17-year veteran of the Cook Medical organization, has been named vice president of administrative services and payroll.
• Cook Medical Brings New Beginning to Canton
  Canton, Ill., December 11, 2008 – Today Cook Medical, in a continuing effort to support local communities, announced new jobs with the development of Cook Canton, a new medical device manufacturing plant to be located at the former International Harvester plant in Canton, Ill.
• Cook Medical Improves Patient Care and Changes Economics for Healthcare Providers with Field-Proven Resonance® Metallic Ureteral Stent
  Bloomington, Ind., December 2, 2008 – Following its first year in use, the Cook Medical Resonance® Metallic Ureteral Stent has proven to successfully relieve extrinsic ureteral compression, a painful and often debilitating side effect of cancer. In addition, the Resonance Stent can remain in the patient for up to 12 months, resulting in a reduction of the costs accrued by both patients and their health care facilities stemming from the numerous interventions needed with alternative care. Additionally, long-term cancer patients may have health insurance policies that cap reimbursement for repeated procedures. As a result, charges for repeated stent changes may go unpaid.
• Cook Medical Receives Conditional Approval from FDA to Begin Clinical Trial for Zenith® Low Profile AAA Endovascular Graft
  New York, NY, November 20, 2008 – Cook Medical, the world leader in endovascular repair of aortic disease, has received Investigational Device Exemption (IDE) conditional approval from the U.S. Food and Drug Administration (FDA) to begin a clinical trial for its Zenith Low Profile Abdominal Aortic Aneurysm (AAA) Endovascular Graft. The trial, which will include 24 sites, is designed to evaluate the safety and effectiveness of the smaller endograft delivery system in 120 patients, enabling the endovascular treatment of AAA patients with smaller vascular access vessels who otherwise may not have been candidates for minimally invasive endovascular treatment. The company announced the conditional IDE approval at this year's VEITHsymposium, a five-day, rapid-fire event featuring presentations from world-renowned vascular specialists.
• Cook Medical's Aortic Intervention Division Builds On Success With Innovative, New Minimally Invasive Treatments for Aortic Diseases
  New York, NY, November 20, 2008 – According to the Society for Vascular Surgery, approximately 200,000 people in the U.S. are diagnosed with an abdominal aortic aneurysm (AAA) each year, while another 15,000 cases of thoracic aortic aneurysms (TAA) are diagnosed annually. With an increasing aging population in which aortic disease occurs most commonly, Cook Medical continues to reinforce its unwavering commitment to delivering the industry's most innovative aortic disease treatment devices to significantly improve patient outcomes.
• Cook Group To Renovate Downtown Canton Buildings
  Canton, IL, November 14, 2008 – CGI Real Estate Holdings, LLC, a Bloomington Indiana-based Cook Group company, purchased two buildings in downtown Canton, in June. The Randolph building, built in 1883, located at 3 & 5 East Side Square and 15 East Side Square are now being renovated.
• Global Therapeutics Initiates Trial of Next Generation Drug-Eluting Stent Using RNA Therapeutic Agent to Treat Coronary Artery Disease
  Broomfield, Colo. – Global Therapeutics, a leading developer of innovative solutions for the cardiology market, today announced initiation of the world's first clinical trial of a drug eluting stent that uses an antisense RNA therapeutics agent aimed at silencing one of the genes (c-myc) responsible for causing arteries to reclose after stenting (restenosis).
• Next Generation, Radically Smaller Aortic Aneurysm Endograft and Delivery System From Cook Medical Submitted For Clinical Trial Approval
  Bloomington, Ind., November 6, 2008 – Cook Medical, the world leader in endovascular repair of aortic disease, has submitted an Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration for its new Zenith® Low Profile Abdominal Aortic Aneurysm (AAA) Endovascular Graft. With IDE approval, Cook will initiate a clinical trial to evaluate the safety and efficacy of the radically smaller endograft delivery system, that will permit treatment of AAA patients with smaller vascular anatomies who otherwise may not have been candidates for minimally invasive endovascular treatment.
• Cook Medical Introduces Ciaglia Blue Dolphin™ Percutaneous Dilational Tracheostomy Device
  Bloomington, Ind., October 30, 2008 – Cook Medical announced today the availability of the Ciaglia Blue Dolphin™ Balloon Percutaneous Tracheostomy Introducer, the first device for percutaneous dilational tracheostomy (PDT) procedures that combines balloon dilation and tracheal tube insertion into one step.
• Local Volunteers in Medicine Clinic To Receive New Medical Facility
  Bloomington, Ind., October 30, 2008 – Patients and volunteer staff at Volunteers in Medicine Clinic of Monroe County (VIM) will have a newly refurbished medical facility which will better enable the local organization to provide primary and preventive medical services to the uninsured and economically disadvantaged in Monroe and Owen Counties. The facility, which is an existing medical office at 811 W. Second St. near Bloomington Hospital, was purchased and refitted for VIM's needs by Cook Medical and will be ready for occupancy January 1. VIM will lease the building from Cook for $1 a year, Cook officials said.
• Cook Medical Brings Power Injection Capability of Contrast Media to Spectrum® Antimicrobial Central Venous Catheter Line
  Bloomington, Ind. – Responding to industry demand for an antimicrobial impregnated central venous catheter capable of withstanding pressure injection rates required for CT scans, Cook Medical has received U.S. Food and Drug Administration 510(k) clearance for a power injectable indication for sizes 7-10 French of its Spectrum® Antibiotic Central Venous Catheters, the company announced today.
• Cook Medical Receives CE Mark Approval for MiraFlex™ High Flow Microcatheter
  Bjaeverskov, Denmark, October 27, 2008 – Cook Medical, the world sales leader in the embolisation market, has received CE Mark approval for its MiraFlex™ High Flow Microcatheter. Specially engineered to complement the existing offering of Cook embolisation products and coils, MiraFlex High Flow embodies the latest innovation in microcatheter technology designed to enhance traceability necessary for accessing the most distal vasculature. The catheter is indicated for use in small vessel or superselective anatomy for diagnostic and interventional procedures.
• Cook Medical Announces the North American Launch of Advance® 18LP PTA Balloon Dilatation Catheter
  Bloomington, Ind., October 20, 2008 – As part of an ongoing effort to expand its comprehensive offering of diagnostic and interventional devices, Cook Medical announced today the North American launch of its Advance® 18LP Balloon Dilatation Catheter. With a low crossing profile and small sheath compatibility, Advance 18LP is designed to provide physicians with superior deliverability.
• Cook Medical Launches New Generation of Advanced Biodesign Technology for Treatment of Hernia Repair and Other Soft Tissue Repair Procedures
  San Francisco, October 14, 2008 – In an ongoing commitment to soft tissue repair innovation, Cook Medical announced the global launch of the newest generation of its Biodesign™ technology at the 2008 Clinical Congress of the American College of Surgeons. Cook's Biodesign product line establishes a new category in tissue repair that combines the best attributes of synthetic mesh and biologic grafts while reducing disadvantages of those materials including erosion and infection. Based on the breakthrough technology that has made the original Surgisis material from Cook an advanced tissue repair solution, the newly enhanced Biodesign base material now offers surgeons better handling characteristics, long-term strength and faster tissue remodelling, thereby delivering better surgical outcomes an